Cover Image
市場調查報告書

生物學心臟瓣膜的全球市場:醫療設備的開發平台評估

Tissue Heart Valves - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 365829
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
生物學心臟瓣膜的全球市場:醫療設備的開發平台評估 Tissue Heart Valves - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年08月01日 內容資訊: 英文 73 Pages
簡介

本報告提供全球生物學心臟瓣膜的市場上,的主要開發中產品與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 生物學心臟瓣膜概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 生物學心臟瓣膜的企業:各臨床實驗階段的開發中產品
  • 生物學心臟瓣膜:各臨床實驗階段的開發中產品

第5章 生物學心臟瓣膜市場:企業、產品概要

  • Children's Hospital Boston
    • 開發中產品及進行中的臨床實驗概要
  • Colibri Heart Valve, LLC
  • CorMatrix Cardiovascular, Inc.
  • CryoLife, Inc.
  • Cytograft Tissue Engineering, Inc.
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Medtronic plc
  • Revivicor, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stellenbosch University
  • Tendyne Medical, Inc.
  • Tissue Regenix Ltd
  • University of California, Irvine
  • University of Cambridge
  • University of Minnesota
  • ValveXchange, Inc. (Inactive)
  • VueKlar Cardiovascular Ltd.

第6章 生物學心臟瓣膜市場:目前的趨勢 (共24件)

第7章 附錄

圖表一覽

目錄
Product Code: GDME0217EPD

GlobalData's Medical Devices sector report, "Tissue Heart Valves - Medical Devices Pipeline Assessment, 2016" provides an overview of Tissue Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates and the number of trials for the key Tissue Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Tissue Heart Valves Overview

3. Products under Development

  • 3.1. Tissue Heart Valves - Pipeline Products by Stage of Development
  • 3.2. Tissue Heart Valves - Pipeline Products by Segment
  • 3.3. Tissue Heart Valves - Pipeline Products by Territory
  • 3.4. Tissue Heart Valves - Pipeline Products by Regulatory Path
  • 3.5. Tissue Heart Valves - Pipeline Products by Estimated Approval Date
  • 3.6. Tissue Heart Valves - Ongoing Clinical Trials

4. Tissue Heart Valves - Pipeline Products under Development by Companies

  • 4.1. Tissue Heart Valves Companies - Pipeline Products by Stage of Development
  • 4.2. Tissue Heart Valves - Pipeline Products by Stage of Development

5. Tissue Heart Valves Companies and Product Overview

  • 5.1. Children's Hospital Boston Company Overview
    • 5.1.1. Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Colibri Heart Valve, LLC Company Overview
    • 5.2.1. Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. CorMatrix Cardiovascular, Inc. Company Overview
    • 5.3.1. CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. CryoLife, Inc. Company Overview
    • 5.4.1. CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Cytograft Tissue Engineering, Inc. Company Overview
    • 5.5.1. Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Edwards Lifesciences Corporation Company Overview
    • 5.6.1. Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. LivaNova PLC Company Overview
    • 5.7.1. LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Medtronic plc Company Overview
    • 5.8.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Revivicor, Inc. Company Overview
    • 5.9.1. Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.10.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Stellenbosch University Company Overview
    • 5.11.1. Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Tendyne Medical, Inc. Company Overview
    • 5.12.1. Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Tissue Regenix Ltd Company Overview
    • 5.13.1. Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. University of California, Irvine Company Overview
    • 5.14.1. University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. University of Cambridge Company Overview
    • 5.15.1. University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. University of Minnesota Company Overview
    • 5.16.1. University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. ValveXchange, Inc. (Inactive) Company Overview
    • 5.17.1. ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. VueKlar Cardiovascular Ltd. Company Overview
    • 5.18.1. VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview

6. Tissue Heart Valves- Recent Developments

  • 6.1. Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
  • 6.2. Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization
  • 6.3. Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
  • 6.4. Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
  • 6.5. May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.6. May 16, 2016: St. Jude Medical Furthers the Company's Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology
  • 6.7. Apr 07, 2016: St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement
  • 6.8. Apr 06, 2016: Cardiothoracic and Vascular Surgeons, In Collaboration with Heart Hospital of Austin, First in Texas to Implant Sutureless Valve For Aortic Valve Replacement Surgery
  • 6.9. Apr 04, 2016: LivaNova Announces the First Patient Enrolled in the PERSIST-AVR Trial
  • 6.10. Mar 08, 2016: LivaNova Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery
  • 6.11. Feb 29, 2016: LivaNova Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve
  • 6.12. Feb 02, 2016: Edwards Lifesciences Reports Fourth Quarter Results
  • 6.13. Feb 01, 2016: LivaNova Announces FDA Approval of Stented Heart Valve CROWN PRT for Aortic Valve Disease
  • 6.14. Jan 11, 2016: LivaNova Announces Approval of Perceval
  • 6.15. Nov 17, 2015: New 10-Year Study Demonstrates Freedom Solo Stentless Aortic Valve Excellent Hemodynamic Performance and Long-term Durability
  • 6.16. Oct 26, 2015: Edwards Lifesciences Reports Third Quarter Results-2015
  • 6.17. Oct 08, 2015: MValve Technologies Raises Additional Funds through Private Placement of Shares
  • 6.18. Oct 05, 2015: Sorin Group Starts First Randomized, Controlled Trial Comparing the Perceval Sutureless Valve to Standard Bioprostheses
  • 6.19. Sep 01, 2015: Max Page Receives a New Heart Pacemaker Pulse Generator from Children's Hospital Los Angeles
  • 6.20. Aug 27, 2015: Children's Hospital Los Angeles Cardiologists Perform Melody Heart Valve Implant in Child Actor Max Page, the Little Darth Vader in the 2011. VW Super Bowl Commercial
  • 6.21. Aug 05, 2015: Health Canada Grants Approval For Sorin's Perceval Sutureless Aortic Valve
  • 6.22. Jul 30, 2015: Abbott Labs Acquires Remaining Stake in Tendyne for USD250 Million
  • 6.23. Jul 30, 2015: Abbott Labs Enters into Option Agreement to Acquire Cephea Valve Technologies
  • 6.24. Jul 28, 2015: Edwards Lifesciences Reports Second Quarter Results

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development
  • Table 2: Tissue Heart Valves - Pipeline Products by Segment
  • Table 3: Tissue Heart Valves - Pipeline Products by Territory
  • Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
  • Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
  • Table 6: Tissue Heart Valves - Ongoing Clinical Trials
  • Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development
  • Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development
  • Table 9: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Heart Valve Leaflet - Product Status
  • Table 11: Heart Valve Leaflet - Product Description
  • Table 12: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Pulmonary Valve - Product Status
  • Table 14: Pulmonary Valve - Product Description
  • Table 15: Sutureless Surgical Aortic Valve - Product Status
  • Table 16: Sutureless Surgical Aortic Valve - Product Description
  • Table 17: CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: CorMatrix ECM - Heart Valve Repair - Product Status
  • Table 19: CorMatrix ECM - Heart Valve Repair - Product Description
  • Table 20: CorMatrix ECM - Heart Valve Replacement - Product Status
  • Table 21: CorMatrix ECM - Heart Valve Replacement - Product Description
  • Table 22: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: CryoValve SGAV - Product Status
  • Table 24: CryoValve SGAV - Product Description
  • Table 25: Synergraft Xenograft Heart Valve - Product Status
  • Table 26: Synergraft Xenograft Heart Valve - Product Description
  • Table 27: Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Cytograft Valve - Product Status
  • Table 29: Cytograft Valve - Product Description
  • Table 30: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: GLX Aortic Conduit - Product Status
  • Table 32: GLX Aortic Conduit - Product Description
  • Table 33: INSPIRIS Platform - Product Status
  • Table 34: INSPIRIS Platform - Product Description
  • Table 35: INTUITY ELITE - Product Status
  • Table 36: INTUITY ELITE - Product Description
  • Table 37: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: CROWN PRT - Product Status
  • Table 39: CROWN PRT - Product Description
  • Table 40: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Closed-Chest Aortic Tissue Valve - Product Status
  • Table 42: Closed-Chest Aortic Tissue Valve - Product Description
  • Table 43: Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Heart Valve - Product Status
  • Table 45: Heart Valve - Product Description
  • Table 46: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Tissue Based Cardiac Valve - Product Status
  • Table 48: Tissue Based Cardiac Valve - Product Description
  • Table 49: Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Percutaneous Heart Valve - Product Status
  • Table 51: Percutaneous Heart Valve - Product Description
  • Table 52: Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
  • Table 54: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
  • Table 55: Tendyne Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 56: Tendyne Bioprosthetic Mitral Valve Implantation System - Early Feasibility Study of the Tendyne Mitral Valve System
  • Table 57: Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Efficacy of Tendyne Bioprosthetic Mitral Valve System in Subjects with Symptomatic Mitral Regurgitation of Degenerative or Functional Etiology
  • Table 58: Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Performance of the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) in Inoperable Subjects with Mitral Regurgitation (MR)
  • Table 59: Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Cardiopure - Aortic Heart Valve - Product Status
  • Table 61: Cardiopure - Aortic Heart Valve - Product Description
  • Table 62: Cardiopure - Pulmonary Heart Valve - Product Status
  • Table 63: Cardiopure - Pulmonary Heart Valve - Product Description
  • Table 64: CardioPure HV - Product Status
  • Table 65: CardioPure HV - Product Description
  • Table 66: dCELL Porcine Aortic Heart Valve - Product Status
  • Table 67: dCELL Porcine Aortic Heart Valve - Product Description
  • Table 68: University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Bileaflet Bioprosthetic Mitral Valve - Product Status
  • Table 70: Bileaflet Bioprosthetic Mitral Valve - Product Description
  • Table 71: Bovine Pericardium Heart Valve - Product Status
  • Table 72: Bovine Pericardium Heart Valve - Product Description
  • Table 73: Heart Valve Leaflets - Product Status
  • Table 74: Heart Valve Leaflets - Product Description
  • Table 75: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Polymeric Heart Valve - Product Status
  • Table 77: Polymeric Heart Valve - Product Description
  • Table 78: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
  • Table 79: Tissue-Engineered Paediatric Heart Valve - Product Status
  • Table 80: Tissue-Engineered Paediatric Heart Valve - Product Description
  • Table 81: ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 82: Vanguard System - Product Status
  • Table 83: Vanguard System - Product Description
  • Table 84: Vitality Exchangeable Valve System - Product Status
  • Table 85: Vitality Exchangeable Valve System - Product Description
  • Table 86: VXi Vanguard II - Product Status
  • Table 87: VXi Vanguard II - Product Description
  • Table 88: VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: MR-Enhancing Percutaneous Heart Valve - Product Status
  • Table 90: MR-Enhancing Percutaneous Heart Valve - Product Description
  • Table 91: Glossary

List of Figures

  • Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development
  • Figure 2: Tissue Heart Valves - Pipeline Products by Segment
  • Figure 3: Tissue Heart Valves - Pipeline Products by Territory
  • Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
  • Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
  • Figure 6: Tissue Heart Valves - Ongoing Clinical Trials
Back to Top